Extreme weight gain in a youth with schizophrenia: risk/benefit considerations.
作者信息
Webster Duncan, Devarajan Sivakumaran, Gallant Janet, Harris Andrew, Kopala Lili C
出版信息
Schizophr Res. 2002 Jul 1;56(1-2):187-9. doi: 10.1016/s0920-9964(01)00253-5.
Abstract
摘要
相似文献
1
Extreme weight gain in a youth with schizophrenia: risk/benefit considerations.一名患有精神分裂症的青少年体重急剧增加：风险/获益考量
Schizophr Res. 2002 Jul 1;56(1-2):187-9. doi: 10.1016/s0920-9964(01)00253-5.
2
Weight gain and antipsychotic medications.体重增加与抗精神病药物
J Clin Psychiatry. 1999 May;60(5):336-7. doi: 10.4088/jcp.v60n0512a.
3
Six-month review of weight and metabolic parameters in patients receiving clozapine, risperidone, olanzapine, or quetiapine.接受氯氮平、利培酮、奥氮平或喹硫平治疗的患者体重及代谢参数的六个月回顾
J Clin Psychiatry. 2003 Sep;64(9):1133-4. doi: 10.4088/jcp.v64n0921f.
4
Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.使用非典型抗精神病药物治疗的患者的血清瘦素和甘油三酯水平
J Clin Psychiatry. 2003 May;64(5):598-604. doi: 10.4088/jcp.v64n0516.
5
Weight gain and antipsychotic medication: differences between antipsychotic-free and treatment periods.体重增加与抗精神病药物：未使用抗精神病药物时期与治疗时期的差异
J Clin Psychiatry. 2001 Sep;62(9):694-700. doi: 10.4088/jcp.v62n0906.
6
Novel antipsychotics: comparison of weight gain liabilities.新型抗精神病药物：体重增加风险的比较。
J Clin Psychiatry. 1999 Jun;60(6):358-63.
7
The effects of risperidone and olanzapine on the indications for clozapine.利培酮和奥氮平对氯氮平适应证的影响。
Psychopharmacol Bull. 1998;34(1):83-7.
8
Weight change and atypical antipsychotic treatment in patients with schizophrenia.精神分裂症患者的体重变化与非典型抗精神病药物治疗
J Clin Psychiatry. 2001;62 Suppl 2:41-4.
9
Cognitive behavior therapy for weight gain.针对体重增加的认知行为疗法。
Am J Psychiatry. 2001 Jun;158(6):971. doi: 10.1176/appi.ajp.158.6.971.
10
Relative weight gain among antipsychotics.抗精神病药物之间的相对体重增加。
J Clin Psychiatry. 1999 Oct;60(10):706-8. doi: 10.4088/jcp.v60n1014.
Zotero 插件